In December 2025, J.P. Morgan upgraded Recursion Pharmaceuticals after REC-4881 showed rapid, durable polyp burden reductions and a favorable safety profile in familial adenomatous polyposis patients, ...
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...
In a climate of escalating regional tensions, Hezbollah is exploring a diplomatic settlement aimed at neutralizing threats from the "Trump-Netanyahu" alliance, a media report said on Monday. Recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results